$MTD

Is Mettler-Toledo Stock Underperforming the Nasdaq?

Mettler-Toledo (MTD), a $25.9B diagnostics and research company, saw its stock reach a 52-week high of $1525.17 but has since fallen 15.1%. It outperformed the Nasdaq Composite over the past three months but lagged over the past year. MTD's Q2 2026 revenue was $1B, with adjusted EPS of $11.46, beating estimates. The company raised its full-year EPS guidance to $47.33. Analysts have a 'Moderate Buy' consensus rating with a mean price target of $1,464.60, implying 13.7% upside.

Original reporting
Published Sep 15, 2026, 10:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 11:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Mettler-Toledo Stock Underperforming the Nasdaq? — source image
Decision brief

The 30-second read

$MTDBullishHigh
01

Why it matters

Earnings beat and guidance raise provide a fresh catalyst for the stock.

02

Market read

First-report earnings data with guidance raise offers actionable insight for traders.

03

What to watch

Potential headwinds from slowing demand in Chinese operations.

Relevance 8/10Novelty 8/10Timing: post Q2 2026 earnings release

Background

Mettler-Toledo is a $25.9B large-cap manufacturer of precision instruments.

Company-level read

Ticker impact

$MTDBullishHigh confidence
Context

Q2 2026 earnings beat and raised full-year EPS guidance to $47.33, with revenue up 4.5% to $1B.

Expected impact

Potential price appreciation toward the $1,464.60 target.

Evidence & confidence

Beat on EPS, higher guidance, and strong free cash flow margin indicate improved profitability.

Market effects

Positive earnings may lift the diagnostics and research equipment sector.

European and Asian operations could benefit from improved cash flow.

Large-cap earnings contribute to overall market sentiment.

Counterpoint

Guidance increase is modest; price may already reflect expectations.

Key entities

  • Mettler-Toledo International Inc.

    Precision instruments manufacturer.

Related articles

$MTDHigh

Redburn starts Mettler-Toledo at Sell, sees valuation outpacing growth

Redburn initiated coverage of Mettler-Toledo (MTD) with a Sell rating and a $1,200 price target, citing a premium valuation and modest growth outlook. The brokerage expects revenue to reach $4.25B in 2026 and $4.44B in 2027, with adjusted EPS of $47.29 and $51.40, respectively. Redburn highlights competition and pressure in China as concerns, despite the company's strong returns and market position.

$MTDHighAI 9/10

Mettler-Toledo (MTD) Q2 2026 Earnings Call Transcript

Mettler-Toledo (MTD) reported Q2 2026 net sales of $1.027B, up 4% reported (6% local currency). Adjusted EPS was $11.46, up 14%. Adjusted operating margin was 29.3%. The company raised full-year 2026 guidance to 4% to 5% local currency revenue growth and adjusted EPS of $47.15 to $47.50, and plans $875M share repurchases.

$MTDMed

5 Insightful Analyst Questions From Mettler

Mettler-Toledo (MTD) reported Q2 revenue of $1.03B, matching analyst estimates, with 4.5% YoY growth. Adjusted EPS was $11.46 versus $10.81 expected, and operating margin rose to 30.6%. Management raised full-year Adjusted EPS guidance to $47.33 midpoint. Analysts focused on China demand, lab rebound durability, pricing, and biopharma/reshoring momentum.

$MTDHighAI 9/10

MTD Q2 FY2026 earnings call — BigGo Finance

Mettler-Toledo (MTD) reported Q2 FY2026 revenue of $1.0B, up 7% YoY (6% local currency), beating prior guidance. Adjusted EPS rose 14% to $11.46. Organic local-currency sales grew 4%, with acquisitions ~1.5%. The company raised full-year outlook to 4% to 5% local-currency sales growth and adjusted EPS of $47.15 to $47.50.

$MTDMed

Toledo (NYSE:MTD) Reports Q2 CY2026 In Line With Expectations

Precision measurement company Mettler-Toledo (NYSE: MTD) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.5% year on year to $1.03 billion. Its non-GAAP profit of $11.46 per share was 6.1% above analysts’ consensus estimates. Is now the time to buy Mettler-Toledo? Find out by accessing our full research report, it’s free.